Authors:
Kornblith, AB
Herndon, JE
Zuckerman, E
Godley, PA
Savarese, D
Vogelzang, NJ
Holland, JC
Citation: Ab. Kornblith et al., The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study, ANN ONCOL, 12(5), 2001, pp. 633-641
Authors:
Safran, H
Moore, T
Iannitti, D
Dipetrillo, T
Akerman, P
Cioffi, W
Harrington, D
Quirk, D
Rathore, R
Cruff, D
Vakharia, J
Vora, S
Savarese, D
Wanebo, H
Citation: H. Safran et al., Paclitaxel and concurrent radiation for locally advanced pancreatic cancer, INT J RAD O, 49(5), 2001, pp. 1275-1279
Authors:
Savarese, D
Taplin, ME
Halabi, S
Hars, V
Kreis, W
Vogelzang, N
Citation: D. Savarese et al., A phase II study of docetaxel (Taxotere), estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: Preliminary results of cancer and leukemia group B trial 9780, SEMIN ONCOL, 26(5), 1999, pp. 39-44